期刊文献+

CD44v6、p27表达与大肠癌临床病理学因素的关系 被引量:3

Expression and clinicopathologic significance of COn4v6 and p27 in colorectal carcinomas
原文传递
导出
摘要 目的探讨CD44v6和p27在大肠癌中的表达及其临床意义。方法对50例手术切除的大肠癌新鲜标本及相应的正常大肠黏膜,应用流式细胞术(FCM)检测CD44v6的表达;同步制备上述病例大肠癌组织石蜡标本,采用免疫组织化学方法检测大肠癌组织中p27的表达,结合病理及临床资料进行统计学分析。结果CD44v6和p27在大肠癌组织及正常黏膜组织中表达存在明显差异(P〈0.01),而且CD44v6和p27的表达与大肠癌的分化程度、有无淋巴结转移、有无远端器官转移、Duke分期及预后相关(P值均〈0.05),CD44v6。的表达与大肠癌的浸润深度无明显相关(P〉0.05),但p27的表达与大肠癌的浸润深度明显相关(P〈0.05)。结论CD44v6和p27的表达与大肠癌的临床病理学特征密切相关,两者在大肠癌组织中的表达呈一定的负相关,同时检测二者对判断大肠癌的恶性程度、复发转移潜能,评价患者的预后及术后选择合理的治疗方案具有一定的参考价值。 Objective To observe the expression and reveal clinical significance of CD44v6 and p27 in colorectal carcinoma. Methods Collecting 50 cases of fresh specimen of coloreetal carcinoma and normal mucous from excision operation. CD44v6 expression was detected by means of FCM in 50 cases of eolorectal carcinoma and corresponding normal mucous, p27 protein was studied by SP immunohistoehemical method. Analysis of statistics was performed by combining clinical and patholoical materials. Results CD44v6 and p27 expression in colorectal carcinoma was significantly higher than that in normal mucous (P 〈0.01). As well as the expression of CD44v6 and p27 was obviously associated with differentiated grade, lymph node metastasis, distant metastasis and Dukes stage (P 〈0.05). The expression of CD44v6 was not evidently correlated with the depth of tumor invasion(P 〉0.05), but the expression of p27 was correlated with the depth of tumor invasion(P 〈0.05). Conclusion The expression of CD44v6 and p27 is markedly related with clinicopathological characters of colorectal carcinoma.CD44v6 expression and p27 expression are obvious negative relationship in colorectal carcinoma. There is a certain value of reference for assessing the malignant grade and the potential of recurrence and metastasis,evaluating patient prognosis and selecting rational treatment after operation.
出处 《肿瘤研究与临床》 CAS 2009年第9期597-599,共3页 Cancer Research and Clinic
关键词 肠肿瘤 流式细胞术 免疫组化 抗原 CD44V6 P27 Intestinal neoplasms Flow cytometry Immuno histochemistry Antigen, CD44v6 p27
  • 相关文献

参考文献5

二级参考文献39

  • 1王莉.CD44基因与大肠癌[J].国外医学(肿瘤学分册),1997,24(1):48-49. 被引量:10
  • 2[1]Polyak K,Kato JY,Solomon MJ,et al.Protein p27Kipl,a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest [J] . Genes Dev,1994,8:9- 22. 被引量:1
  • 3[2]Esposito V, Baldi A, De Luca A,et al. Prognostic role of the cyclin-dependant kinase inhibitor p27 in non-small cell lung cancer [J]. Cancer Res, 1997,57:3381- 3385. 被引量:1
  • 4[3]Tan P,Cady B, Wanner M,et al. The cell cycle inhibitor p27 is an independent prognostic marker in(T1a,b)invasive breast carcinomas [J]. Cancer Res,1997,57:1259- 1263. 被引量:1
  • 5[4]Hirano K, Minamoto T. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum- - a comparative clinicopathologic and molecular analysis [J]. Cancer Detect Prev,2000,24:343- 355. 被引量:1
  • 6[5]Singh SP, Lipman J, Goldman H,et al. Loss or altered subcellular localization of p27 in Barrett s associated adenocarcinoma [J]. Cancer Res,1998,58:1730- 1735. 被引量:1
  • 7[6]Yang RM, Naitoh J, Murphy M, et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer[J]. J Urol,1998.159:941- 945. 被引量:1
  • 8[7]Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27kIP1 in multistage colorectal carcinogenesis[J]. Cancer Res,1998,58:114- 122. 被引量:1
  • 9[8]Zhang H, Sun XF. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer [J] . Int J Oncol,2001,19:49- 52. 被引量:1
  • 10Tsvetkov LM,Yeh KH,Lee SJ,et al.p27 (Kip1) ubiquitination and degradation is regulated by the SCF (Skp2) complex through phosphorylated Thr187 in p27[J].Curr Biol,1999,9(12):661~664 被引量:1

共引文献21

同被引文献30

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem ceils. Nature, 2001, 414:105-111. 被引量:1
  • 2Salnikov A~, Gladkich J, Moldenhauer G, et al. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. Int J Cancer, 2010, 126: 950-958. 被引量:1
  • 3Pallini R, Ricci-Vitiani L, Montano N, et al. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer, 2011, 117: 162-174. 被引量:1
  • 4Fang DD, Kim YJ, Lee CN, et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer, 2010, 102: 1265-1275. 被引量:1
  • 5Hong SP, Wen J, Bang S, et al. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer ceils. Int J Cancer, 2009, 125:2323-2331. 被引量:1
  • 6Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65:109467 10951. 被引量:1
  • 7Chen YW, Chen KH, Huang PI, et al. Cucurbitaein I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1 (+) cells. Mol Cancer Ther, 2010, 9: 2879-2892. 被引量:1
  • 8Weichert W, Denkert C, Burkhardt M, et al. Cytoplasmic CD24 expression in colorectal cancer independently con-elates with shortened patient survival. Clin Cancer Res, 2005, 11: 6574-6581. 被引量:1
  • 9Lira SC, Oh SH. The role of CD24 in various human epithelial neoplasms. Pathol Res Praet, 2005, 201: 479-486. 被引量:1
  • 10Hsi ED. A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch Pathol Lab Med, 2001, 125: 289-294. 被引量:1

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部